The neuropathogenic contributions of lysosomal dysfunction

Journal of Neurochemistry

Volumn 83, Issue 3, 2002, Pages 481-489

  Bahr, Ben A ^a   Bendiske, Jennifer ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Alzheimers disease; Amyloidogenic processing; Lysosomes; Parkinson's disease; Synaptic loss; Tau

Indexed keywords

ALPHA SYNUCLEIN; ENZYME; HUNTINGTIN; PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; ENZYME DEFICIENCY; HUMAN; HUNTINGTON CHOREA; LYSOSOME; LYSOSOME STORAGE DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SYNAPSE;

ALPHA-SYNUCLEIN; AMYLOID; ANIMALS; HUMANS; LYSOSOMAL STORAGE DISEASES, NERVOUS SYSTEM; LYSOSOMES; MACROMOLECULAR SUBSTANCES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SYNUCLEINS; TAU PROTEINS;

EID: 0036830228     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01192.x     Document Type: Review

References (83)

1. Amtul Z., Lewis P. A., Piper S., Crook R., Baker M., Findlay K., Singleton A., Hogg M., Younkin L., Younkin S. G., Hardy J., Hutton M., Boeve B. F., Tang-Wai D. and Golde T. E. (2002) A presenilin 1 mutation associated with familial frontotemporal dementia inhibits γ-secretase cleavage of APP and notch. Neurobiol. Dis. 9, 269-273.
2. Auer I. A., Schmidt M. L., Lee V. M., Curry B., Suzuki K., Shin R. W., Pentchev P. G., Carstea E. D. and Trojanowski J. Q. (1995) Paired helical filament tau (PHF-tau) in Niemann-Pick type C disease is similar to PHF-tau in Alzheimer's disease. Acta Neuropathol. (Berlin) 90, 547-551.
3. Bahr B. A. (1995) Long-term hippocampal slices: A model system for investigating synaptic mechanisms and pathologic processes. J. Neurosci. Res. 42, 294-305.
4. Bahr B. A., Abai B., Gall C. M., Vanderklish P. W., Hoffman K. B. and Lynch G. (1994) Induction of β-amyloid-containing polypeptides in hippocampus: Evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129, 81-94.
5. Bahr B. A., Hoffman K. B., Yang A. J., Hess U. S., Glabe C. G. and Lynch G. (1998) Amyloid β protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397, 139-147.
6. Bahr B. A., Bendiske J., Brown Q. B., Munirathinam S., Caba E., Rudin M., Urwyler S., Sauter A. and Rogers G. (2002) Survival signaling and selective neuroprotection through glutamate transmission. Exp. Neurol. 174, 37-47.
7. Bendiske J., Caba E., Brown Q. B. and Bahr B. A. (2002) Intracellular deposition, microtubule destabilization, and transport failure: An 'early' pathogenic cascade leading to synaptic decline. J. Neuropathol. Exp. Neurol. 61, 640-650.
8. Benowitz L. I., Rodriguez W., Paskevich P., Mufson E. J., Schenk D. and Neve R. L. (1989) The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp. Neurol. 106, 237-250.
9. Bi X., Yong A. P., Zhou J., Ribak C. E. and Lynch G. (2001) Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA 98, 8832-8837.
10. Blomgren K., Zhu C., Wang X., Karlsson J. O., Leverin A. L., Bahr B. A., Mallard C. and Hagberg H. (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: A mechanism of 'pathological apoptosis'? J. Biol. Chem. 276, 10191-10198.
11. Brunk U. and Brun A. (1972) The effect of aging on lysosomal permeability in nerve cells of the central nervous system. An enzyme histochemical study in rat. Histochemie 30, 315-324.
12. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C. M. and Stefani M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
13. Burdick D., Kosmoski J., Knauer M. F. and Glabe C. G. (1997) Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ 1-42, in differentiated PC12 cells. Brain Res. 746, 275-284.
14. Callahan L. M., Vaules W. A. and Coleman P. D. (1999) Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 275-287.
15. Cataldo A. M., Paskevich P. A., Kominami E. and Nixon R. A. (1991) Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10998-11002.
16. Cataldo A. M., Hamilton D. J. and Nixon R. A. (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 640, 68-80.
17. Cataldo A. M., Hamilton D. J., Barnett J. L., Paskevich P. A. and Nixon R. A. (1996) Properties of the endosomal-lysosomal system in the human central nervous system: Disturbance mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16, 186-199.
18. Charles V., Mezey E., Reddy P. H., Dehejia A., Young T. A., Polymeropoulos M. H., Brownstein M. J. and Tagle D. A. (2000) α-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models. Neurosci Lett. 289, 29-32.
19. Cole G. M., Huynh T. V. and Saitoh T. (1989) Evidence for lysosomal processing of amyloid β-protein precursor in cultured cells. Neurochem. Res. 14, 933-939.
20. Cross A. J., Crow T. J., Dawson J. M., Ferrier I. N., Johnson J. A., Peters T. J. and Reynolds G. P. (1986) Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington's disease. J. Neurochem. 47, 882-889.
21. D'Andrea M. R., Nagele R. G., Wang H. Y., Peterson P. A. and Lee D. H. (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120-134.
22. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P. and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
23. Ditaranto K., Tekirian T. L. and Yang A. J. (2001) Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 8, 19-31.
24. El-Agnaf O. M. and Irvine G. B. (2000) Review: Formation and properties of amyloid-like fibrils derived from β-synuclein and related proteins. J. Struct. Biol. 130, 300-309.
25. Evin G., Cappai R., Li Q. X., Culvenor J. G., Small D. H. and Beyreuther K. and Masters C. L. (1995) Candidate γ-secretases in the generation of the carboxyl terminus of the Alzheimer's disease β A4 amyloid: Possible involvement of cathepsin D. Biochemistry 34, 14185-14192.
26. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K. and Hartmann T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98, 5856-5861.
27. Glabe C. (2001) Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17, 137-145.
28. Golde T. E., Estus S., Younkin L. H., Selkoe D. J. and Younkin S. G. (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728-730.
29. Gotz J., Chen F., van Dorpe J. and Nitsch R. M. (2001) Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Aβ 42 fibrils. Science 293, 1491-1495.
30. Haass C., Koo E. H., Mellon A., Hung A. Y. and Selkoe D. J. (1992) Targeting of cell-surface β-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
31. Haass C., Hung A. V., Schlossmacher M. G., Teplow D. B. and Selkoe D. J. (1993) β-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024.
32. Hajimohammadreza I., Anderson V. E. R., Cavanagh J. B., Seville M. P., Nolan C. C., Anderton B. H. and Leigh P. N. (1994) β-amyloid precursor protein fragments and lysosomal dense bodies are found in rat brain neurons after ventricular infusion of leupeptin. Brain Res. 640, 25-32.
33. Hardy J., Duff K., Hardy K. G., Perez-Tur J. and Hutton M. (1998) Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau. Nat. Neurosci. 1, 355-358.
34. Hempen B. and Brion J. P. (1996) Reduction of acetylated α-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55, 964-972.
35. Hsia A. Y., Masliah E., McConlogue L. YuG. Q., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A. and Mucke L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228-3233.
36. Ikeda K., Akiyama H., Arai T. et al. (1998) Alz-5O/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains. Neurosci. Lett. 258, 113-116.
37. Ikeda K., Akiyama H., Arai T., Kondo H., Haga C., Tsuchiya K., Yamada S. and Murayama S. (2000) Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: Evidence for the lysosomal degradation of altered tau in human brain? Neurosci. Lett. 284, 187-189.
38. Ivy G. O. (1992) Protease inhibition causes some manifestations of aging and Alzheimer's disease in rodent and primate brain. Ann. N. Y. Acad. Sci. 674, 89-102.
39. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N. P., Gerard C., Hama E., Lee H. J. and Saido T. C. (2001) Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550-1552.
40. Kamal A., Almenar-Queralt A., LeBlanc J. F., Roberts E. A. and Goldstein L. S. (2001) Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP. Nature 414, 643-648.
41. Katz M. L., Christianson J. S., Norbury N. E., Gao C. L., Siakotos A. N. and Koppang N. (1994) Lysine methylation of mitochondrial ATP synthase subunit c stored in tissues of dogs with hereditary ceroid lipofuscinosis. J. Biol. Chem. 269, 9906-9911.
42. Kegel K. B., Kim M., Sapp E., McIntyre C., Castano J. G., Aronin N. and DiFiglia M. (2000) Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 20, 7268-7278.
43. Kikugawa K., Beppu M., Kato T., Yamaki S. and Kasai H. (1994) Accumulation of autofluorescent yellow lipofuscin in rat tissues estimated by sodium dodecylsulfate extraction. Mech. Ageing Dev. 74, 135-148.
44. Kim J.-H., Anwyl R., Suh Y.-H., Djamgoz M. B. A. and Rowan M. J. (2001a) Use-dependent effects of amyloidogenic fragments of β-amyloid precursor Protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21, 1327-1333.
45. Kim Y. J., Yi Y., Sapp E., Wang Y., Cuiffo B., Kegel K. B., Qin Z. H., Aronin N. and DiFiglia M. (2001b) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. USA 98, 12784-12789.
46. Klafki H. W., Abramowski D., Swoboda R., Paganetti P. A. and Staufenbiel M. (1996) The carboxyl termini of β amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities. J. Biol. Chem. 271, 28655-28659.
47. Koo E. H. and Squazzo S. (1994) Evidence that production and release of amyloid β-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386-17389.
48. Laszlo L., Lowe J., Self T., Kenward N., Landon M., McBride T., Farquhar C., McConnell I., Brown J. and Hope J. (1992) Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J. Pathol. 166, 333-341.
49. Lewis J., Dickson D. W., Lin W. L., Chisholm L., Corral A., Jones G., Yen S. H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M. and McGowan E. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491.
50. Li H., Li S. H., Yu Z. X., Shelbourne P. and Li X. J. (2001) Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J. Neurosci. 21, 8473-8481.
51. Lim F., Hernandez F., Lucas J. J., Gomez-Ramos P., Moran M. A. and Avila J. (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and tau filaments in forebrain. Mol. Cell. Neurosci. 18, 702-714.
52. Loftus S. K., Morris J. A., Carstea E. D., Gu J. Z., Cummings C., Brown A., Ellison J., Ohno K., Rosenfeld M. A., Tagle D. A., Pentchev P. G. and Pavan W. J. (1997) Murine model of Niemann-Pick C disease: Mutation in a cholesterol homeostasis gene. Science 277, 232-235.
53. Masliah E. and Licastro F. (2000) Neuronal and synaptic loss, reactive gliosis, microglial response, and induction of the complement cascade in Alzheimer's disease, in Neurodegenerative Dementias (Clark C. M. and Trojanowski J. Q., eds), pp. 131-146. McGraw-Hill, New York.
54. Masliah E., Iwai A., Mallory M., Ueda K. and Saitoh T. (1996) Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am. J. Pathol. 148, 201-210.
55. Mathews P. M., Guerra C. B., Jiang Y., Grbovic O. M., Kao B. H., Schmidt S. D., Dinakar R., Mercken M., Hille-Rehfeld A., Rohrer J., Mehta P., Cataldo A. M. and Nixon R. A. (2002) Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Aβ secretion: Role for altered lysosomal hydrolase distribution in β-amyloidogenesis. J. Biol. Chem. 277, 5299-5307.
56. McPhie D. L., Golde T., Eckman C. B., Yager D., Brant J. B. and Neve R. L. (2001) β-secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Mol. Brain Res. 97, 103-113.
57. Mesulam M. M. (1999) Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles. Neuron 24, 521-529.
58. Mielke J. G., Murphy M. P., Maritz J., Bengualid K. M. and Ivy G. O. (1997) Chloroquine administration in mice increases β-amyloid immunoreactivity and attenuates kainate-induced blood-brain barrier dysfunction. Neurosci. Lett. 227, 169-172.
59. Mills J. and Reiner P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 443-460.
60. Mucke L., Masliah E., Yu G. O., Mallory M., Rockenstein E. M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K. and McConlogue L. (2000) High-level neuronal Expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
61. Nakamura Y., Takeda M., Suzuki K., Morita K., Tada K., Hariguchi S. and Nishimura R. (1998) Lysosome instability in aged rat brain. Neurosci. Lett. 97, 215-220.
62. Nixon R. A. (2000) A 'protease activation cascade' in the pathogenesis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 924, 117-131.
63. Nixon R. A., Mathews P. M. and Cataldo A. M. (2001) The neuronal endosomal-lysosomal system in Alzheimer's disease. J. Alzheimer's Diease 3, 97-107.
64. Okada M., Miyake T., Kitamura T., Kawasaki K. and Mizushima Y. (1994) Anti-ubiquitin immunoreactivity associates with pyramidal cell death induced by intraventricular infusion of leupeptin in rat hippocampus. Neurosci. Res. 19, 59-66.
65. Oster-Granite M. L., McPhie D. L., Greenan J. and Neve R. L. (1996) Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16, 6732-6741.
66. Oyama F., Murakami N. and Ihara Y. (1998) Chloroquine myopathy suggests that tau is degraded in lysosomes: Implication for the formation of paired helical filaments in Alzheimer's disease. Neurosci. Res. 31, 1-8.
67. Rohn T. T., Head E., Su J. H., Anderson A. J., Bahr B. A., Cotman C. W. and Cribbs D. H. (2001) Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am. J. Pathol. 158, 189-198.
68. Selkoe D. J. (2001a) Alzheimer's disease: Genes, proteins and therapies. Physiol. Rev. 81, 742-761.
69. Selkoe D. J. (2001b) Clearing the brain's amyloid cobwebs. Neuron 32, 177-180.
70. Skovronsky D. M., Pijak D. S., Doms R. W. and Lee V. M. (2000) A distinct ER/IC γ-secretase competes with the proteasome for cleavage of APP. Biochemistry 39, 810-817.
71. Small D. H., Mok S. S. and Bornstein J. C. (2001) Alzheimer's disease and Aβ toxicity: From top to bottom. Nat. Rev. Neurosci. 2, 595-598.
72. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) α-synuclein in Lewy bodies. Nature 388, 839-840.
73. Stefanis L., Larsen K. E., Rideout H. J., Sulzer D. and Greene L. A. (2001) Expression of A53T mutant but not wild-type α-synuclein in PC12 cells induces alteration of the ubiquitin-dependent degradation system, loss of dopamine release and autophagic cell death. J. Neurosci. 21, 9549-9560.
74. Takauchi S. and Miyoshi K. (1989) Degeneration of neuronal processes in rats induced by a protease inhibitor, leupeptin. Acta Neuropathol. (Berl.) 78, 380-387.
75. Takauchi S. and Miyoshi K. (1995) Cytoskeletal changes in rat cortical neurons induced by long-term intraventricular infusion of leupeptin. Acta Neuropathol. (Berlin) 89, 8-16.
76. Terry R. D., Masliah E., Salmon D. P., Butters N., Deteresa R., Hill R., Hansen L. A. and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
77. Vanderklish P. W. and Bahr B. A. (2000) The pathogenic activation of calpain: A marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81, 323-339.
78. Vicente J. S., Munirathinam S. and Bahr B. A. (2002) Calpain-mediated spectrin breakdown identifies vulnerable brain regions at middle age. J. Mol. Biol. Biotech. 3, 1-10.
79. Walkley S. U. (1998) Cellular pathology of lysosomal storage disorders. Brain Pathol. 8, 175-193.
80. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J. and Selkoe D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal longterm potentiation in vivo. Nature 416, 535-539.
81. Yamashima T. (2000) Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol 62, 273-295.
82. Yang A. J., Knauer M., Burdick D. A. and Glabe C. (1995) Intracellular Aβ 1-42 aggregates stimulate the accumulation of stable, insoluble amyloidogenic fragments of the amyloid precursor protein in transfected cells. J. Biol. Chem. 270, 14786-14792.
83. Yang A. J., Chandswangbhuvana D., Margol L. and Glabe C. G. (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis. J. Neurosci. Res. 52, 691-698.